Log In
Print
BCIQ
Print
Print this Print this
 

GNbAC1

  Manage Alerts
Collapse Summary General Information
Company GeNeuro S.A.
DescriptionHumanized mAb targeting the envelop protein of human endogenous retrovirus type W (HERV-W)
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today